English/中文

Product Site

2019-04-19

PharmaBlock Attended APRDL Shedding Light on CMC C...

Recently PharmaBlock attended APRDL 2019 (The Asia Pharma R&D Leaders Summit), which is designed to ...

2019-03-25

2019 April Short Course Photoredox Catalysis in Or...

Course Description Over the last decade, photoredox catalysis has become a valuable mode of act...

2018-11-26

PharmaBlock Begins Operation of New ProcessR&D Cen...

PharmaBlock (USA), Inc. recently completed renovation of its new processR&D center in Philadelphia S...

2018-12-21

PharmaBlock Invests Over 65 Million USD on New Dis...

China, NJ-December 20, 2018- PharmaBlock Sciences (Nanjing), Inc., the leading provider of innovat...

2018-09-28

PharmaBlock Acquires a GMP compliantManufacturing ...

-Facility is acquired from Porton PharmaSolutions Ltd., and operated with GMP compliance.-Located in...

2018-01-01

PharmaBlock Established USA Headquarters in Pennsy...

On January 1st, 2018, PharmaBlock Sciences (Nanjing), Inc., a leading innovative chemistry products ...

2018-07-23

FDA Grants Approval of TIBSOVO®, the First Ora...

CAMBRIDGE, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- - Approval of TIBSOVO® was Based on Phase 1 ...

2018-09-20

PharmaBlock appoints Dr. ShijieZhang as Chief Tech...

PharmaBlockSciences (Nanjing), Inc. (SZSE: 300725), a global leader in providinginnovative chemistry...

2017-11-10

PharmaBlock Listed on Shenzhen Stock Exchange

PharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) was listed on Shenzhen Exchange Stock on Novembe...

2017-01-23

PharmaBlock Team Selected as 2016 NanjingHi-calibe...

In Jan 2017, a team from PharmaBlock was selected as 2016 Nanjing Hi-caliber Talent Team, announced ...

XML 地图 | Sitemap 地图